Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 16,737,109 $ 13,213,929
Other current assets 62,690 15,711
Total current assets 16,799,799 13,229,640
Other non-current assets 68,858 122,381
Total assets 16,868,657 13,352,021
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,176,666 724,165
Total current liabilities 1,176,666 724,165
Total liabilities 1,176,666 724,165
Commitments and contingencies (Note 6)
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 11,453,465 and 10,587,632 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively 11,453 10,587
Additional paid-in capital 47,873,570 38,508,825
Accumulated other comprehensive loss (7,873) (10,970)
Accumulated deficit (32,185,159) (25,880,586)
Total stockholders' equity 15,691,991 12,627,856
Total liabilities and stockholders' equity $ 16,868,657 $ 13,352,021